Cardinal Health, Inc. operates as a global provider of healthcare services and products. With a broad reach across several markets and a diverse customer base, its Pharmaceutical and Medical divisions contribute to its strong market position. However, debt levels and competition in the sector may pose challenges.
The overall fundamental rating for Cardinal Health, Inc. is C+. The following table details the scores for various financial metrics:
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 1 | |
| Return on Assets | 3 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 1 |
The historical data provides a glance at how the scores have evolved:
| Date | Overall Score | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-07-24 | 2 | 4 | 1 | 3 | 1 | 2 | 1 |
| Previously | 0 | 4 | 1 | 3 | 1 | 2 | 1 |
Analysts have provided the following price targets for Cardinal Health, Inc.:
| High | Low | Median | Consensus |
|---|---|---|---|
| 275 | 235 | 255.5 | 255.13 |
Here is the current analyst sentiment for Cardinal Health, Inc.:
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 18 | |
| Hold | 15 | |
| Sell | 0 | |
| Strong Sell | 0 |
Cardinal Health, Inc. exhibits a stable yet unexciting fundamental profile, underlined by a moderate overall rating of C+. With a robust analyst consensus of a "Buy" rating, the stock is perceived as attractive despite the company’s relatively poor metrics in areas like ROE and Debt to Equity. Its significant presence and diversified offerings present growth opportunities, though challenges remain with risk factors including competition and operational efficiency. Potential investors should weigh these elements when considering CAH for their portfolios.
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.